Mybl2 rejuvenates heart explant‐derived cells from aged donors after myocardial infarction

While cell therapy is emerging as a promising option for patients with ischemic cardiomyopathy (ICM), the influence of advanced donor age and a history of ischemic injury on the reparative performance of these cells are not well defined. As such, intrinsic changes that result from advanced donor age...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafatian, Ghazaleh, Kamkar, Maryam, Parent, Sandrine, Michie, Connor, Risha, Yousef, Molgat, André S. D., Seymour, Richard, Suuronen, Erik J., Davis, Darryl R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433005/
https://www.ncbi.nlm.nih.gov/pubmed/32558221
http://dx.doi.org/10.1111/acel.13174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433005/
https://www.ncbi.nlm.nih.gov/pubmed/32558221
http://dx.doi.org/10.1111/acel.13174

Ejemplares similares